Related Experiment Video
Updated: Aug 8, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Richard Smith1, Leah A Owen, Deborah J Trem
1The Center for Children, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA.
Abstract:
Our understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has been limited by a lack of knowledge regarding the tumor cell of origin. To circumvent this, we analyzed the function of EWS/FLI in Ewing's sarcoma itself. By combining retroviral-mediated RNA interference with reexpression studies, we show that ongoing EWS/FLI expression is required for the tumorigenic phenotype of Ewing's sarcoma. We used this system to define the full complement of EWS/FLI-regulated genes in Ewing's sarcoma. Functional analysis revealed that NKX2.2 is an EWS/FLI-regulated gene that is necessary for oncogenic transformation in this tumor. Thus, we developed a highly validated transcriptional profile for the EWS/FLI fusion protein and identified a critical target gene in Ewing's sarcoma development.
Insights
Ongoing EWS/FLI expression drives Ewing sarcoma tumorigenesis. Researchers identified NKX2.2 as a critical EWS/FLI-regulated gene essential for this cancer
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma development is driven by the EWS/FLI fusion protein.
- The specific cell of origin for Ewing sarcoma remains poorly understood.
- Understanding EWS/FLI function within the tumor is crucial.
Purpose of the Study:
- To investigate the role of EWS/FLI in established Ewing sarcoma.
- To identify genes regulated by EWS/FLI in Ewing sarcoma.
- To determine critical EWS/FLI targets involved in oncogenic transformation.
Main Methods:
- Utilized retroviral-mediated RNA interference to suppress EWS/FLI.
- Performed reexpression studies to confirm EWS/FLI requirement.
- Analyzed gene expression profiles to identify EWS/FLI-regulated genes.
Main Results:
- Confirmed that sustained EWS/FLI expression is necessary for the tumorigenic phenotype.
- Developed a comprehensive transcriptional profile of EWS/FLI activity.
- Identified NKX2.2 as a key EWS/FLI-regulated gene essential for transformation.
Conclusions:
- Ongoing EWS/FLI expression is indispensable for Ewing sarcoma maintenance.
- NKX2.2 is a critical downstream target of EWS/FLI in Ewing sarcoma.
- This study provides a validated transcriptional map and identifies a key oncogenic driver.

